The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Biora Therapeutics Secures Additional Funding from Existing Investors
Aug 13, 2024•almost 2 years ago
Contract Type
agreement
San DiegoBiotechnologyHealth CareTherapeutics
Description
Biora Therapeutics announced the signing of financing agreements with its existing convertible notes holders, which is expected to fund the company to important milestones, including anticipated partnering with large pharma. The funding is driven by active pharma collaborator interest in the BioJet™ platform and recent promising clinical trial results from the NaviCap™ platform.
Company Information
Company
Biora Therapeutics
Location
San Diego, California, United States
About
Biora Therapeutics is a clinical-stage biotech developing two smart pill-based therapeutics platforms: the NaviCap™ platform for colon-targeted treatment of IBD, designed to improve patient outcomes through treatment at the site of disease in the gastrointestinal tract, and the BioJet™ platform for oral delivery of large molecules, designed to replace injection with needle-free, oral delivery for better management of chronic diseases.
Predictive Intelligence
Strategic
ML-powered predictions for Biora Therapeutics's next move
San DiegoBiotechnologyHealth CareTherapeutics